MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 ( ibudilast ) for the Post-COVID Condition - MediciNova ( NASDAQ:MNOV )

3 weeks ago

LA JOLLA, Calif., Aug. 29, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market MNOV and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , announces that it has received a Notice of Allowance from the U.S.

Ticker	Sentiment	Impact
MNOV	Neutral	28 %